Skip to content

Development and preliminary application of a needs assessment tool for involuntary admission patients with mental disorders based on Maslow's needs theory

Development and preliminary application of a needs assessment tool for involuntary admission patients with mental disorders based on Maslow's needs theory

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101586
Enrollment
Unknown
Registered
2025-04-27
Start date
2025-05-05
Completion date
Unknown
Last updated
2025-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental Disorders

Interventions

Observation group:None

Sponsors

The Affiliated Brain Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria for psychiatric disorders specified in the International Classification of Diseases, 10th Revision (ICD-10), including but not limited to schizophrenia, bipolar disorder, and depressive disorders; 2.Fulfill Criterion I (risk of self-harm or suicide) or Criterion II (risk of harming others or jeopardizing public safety) for involuntary psychiatric hospitalization; 3.Age >=18 years; 4.Provide informed consent and voluntarily participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patients with end-stage cardiac, hepatic, or renal diseases; 2. Individuals in the acute phase of psychiatric disorders; 3. Pregnant or lactating women; 4. Individuals with severe visual or auditory impairments.

Design outcomes

Primary

MeasureTime frame
Involuntary hospitalization of patients with psychiatric disorders;Reliability and validity;

Countries

China

Contacts

Public ContactAixiang Xiao

The Affiliated Brain Hospital of Guangzhou Medical University

3088545482@qq.com+86 189 2216 5267

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026